Therapeutic Class
Cell and gene sector still facing capacity crunch, say experts
Therapeutic ClassCell and gene sector still facing capacity crunch, say expertsCell and gene sector still facing capacity crunch, say experts
Cell and gene therapy firms still face a capacity crunch – a lack of manufacturing, technology, raw materials that delay projects.